Angela Gueli

409 total citations
13 papers, 151 citations indexed

About

Angela Gueli is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Angela Gueli has authored 13 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Angela Gueli's work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (4 papers). Angela Gueli is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Viral-associated cancers and disorders (4 papers). Angela Gueli collaborates with scholars based in Italy and Egypt. Angela Gueli's co-authors include Corrado Tarella, Marco Ruella, Daniele Caracciolo, Roberto Passera, Cristina Boschini, Alessandro Cignetti, Andrea Rossi, Federica Delaini, Giuseppe Gritti and Alessandro Rambaldi and has published in prestigious journals such as Blood, PLoS ONE and Autoimmunity Reviews.

In The Last Decade

Angela Gueli

12 papers receiving 149 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Gueli Italy 6 96 64 33 32 26 13 151
Agnieszka Giza Poland 8 121 1.3× 84 1.3× 28 0.8× 16 0.5× 37 1.4× 40 177
Konstantinos Christofyllakis Germany 6 45 0.5× 64 1.0× 13 0.4× 13 0.4× 11 0.4× 30 149
Joel Wight Australia 8 104 1.1× 58 0.9× 12 0.4× 15 0.5× 43 1.7× 22 157
Allison Winter United States 8 100 1.0× 117 1.8× 8 0.2× 26 0.8× 67 2.6× 39 221
Maria Moschogiannis Greece 8 130 1.4× 67 1.0× 6 0.2× 24 0.8× 81 3.1× 18 171
Adrian Minson Australia 7 85 0.9× 81 1.3× 18 0.5× 18 0.6× 37 1.4× 23 157
Sergio Fava Italy 5 77 0.8× 75 1.2× 8 0.2× 10 0.3× 46 1.8× 10 165
Massimo Granai Italy 8 88 0.9× 113 1.8× 5 0.2× 49 1.5× 32 1.2× 28 184
Chiara Lobetti‐Bodoni Switzerland 8 159 1.7× 106 1.7× 8 0.2× 20 0.6× 73 2.8× 12 189
Mathieu Simonin France 9 38 0.4× 37 0.6× 17 0.5× 31 1.0× 19 0.7× 27 182

Countries citing papers authored by Angela Gueli

Since Specialization
Citations

This map shows the geographic impact of Angela Gueli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Gueli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Gueli more than expected).

Fields of papers citing papers by Angela Gueli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Gueli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Gueli. The network helps show where Angela Gueli may publish in the future.

Co-authorship network of co-authors of Angela Gueli

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Gueli. A scholar is included among the top collaborators of Angela Gueli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Gueli. Angela Gueli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Derenzini, Enrico, Angela Gueli, Safaa Ramadan, et al.. (2016). Prognostic Value of End of Treatment FDG-PET Scan in T-Cell Lymphoma, a 20-Year Single Institution Study. Blood. 128(22). 3003–3003. 1 indexed citations
2.
Cirillo, S., Riccardo Bruna, Angela Gueli, et al.. (2015). Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma. Clinical Radiology. 71(3). 271–279. 30 indexed citations
3.
Tarella, Corrado, Angela Gueli, Federica Delaini, et al.. (2015). Life Expectancy in Follicular Lymphoma Is Mainly Determined By Response to First LINE Treatment: A LONG-TERM Survey on 597 Patients. Blood. 126(23). 3989–3989. 2 indexed citations
4.
Geuna, Massimo, Alessandro Cignetti, Angela Gueli, et al.. (2014). Normal Circulating B Cells Are Markedly Reduced in Follicular Lymphoma and Diffuse Large B Cell Lymphoma at Diagnosis. Blood. 124(21). 2970–2970. 1 indexed citations
5.
Tarella, Corrado, Angela Gueli, Federica Delaini, et al.. (2014). Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin’s Lymphoma: Correlation with Long-Term Survival. PLoS ONE. 9(9). e106745–e106745. 17 indexed citations
6.
Rambaldi, Alessandro, Cristina Boschini, Giuseppe Gritti, et al.. (2013). The lymphocyte to monocyte ratio improves the IPI‐risk definition of diffuse large B‐cell lymphoma when rituximab is added to chemotherapy. American Journal of Hematology. 88(12). 1062–1067. 53 indexed citations
7.
Ferrero, Simone, Luigia Monitillo, Barbara Mantoan, et al.. (2013). Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. Annals of Hematology. 92(11). 1503–1511. 10 indexed citations
10.
Tarella, Corrado, Angela Gueli, Marco Ruella, & Alessandro Cignetti. (2012). Lymphocyte transformation and autoimmune disorders. Autoimmunity Reviews. 12(8). 802–813. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026